Positron emission tomography scan in cortical visual loss in patients with organophosphate intoxication.
OBJECTIVE
To determine the cerebral metabolism of patients with cortical visual loss.


METHODS
Two observational case studies.


METHODS
Two patients who survived acute organophosphate poisoning with respiratory failure experienced severe visual loss despite relatively normal ophthalmic examination results. Magnetic resonance imaging of the brain revealed no abnormality of the visual system in either patient. Positron emission tomography (PET) was performed in these 2 patients and in 12 normal subjects with fluorine-18 fluorodeoxyglucose (FDG) as a tracer to measure cerebral glucose metabolism for the estimation of neurologic deficit in the visual cortex.


METHODS
The FDG uptake values were measured as nanoCurie per cubic centimeters of tissue (nCi/cc). The relative uptake index in visual cortex was computed as the ratio of uptake of FDG in each region of visual cortex to that of cerebellum (regional visual cortex/cerebellum).


RESULTS
Hypometabolism was observed in the visual cortex of both patients. The relative uptake index of FDG in visual cortex (visual cortex/cerebellum) was significantly decreased in those patients compared with normal subjects.


CONCLUSIONS
In patients with cortical visual loss, conventional neuroimaging techniques can fail to visualize damage that can be detected by PET scanning, and PET analysis may be helpful in estimating the metabolic deficit of visual cortex and in establishing the organic nature of cortical visual loss in these patients.
Wang
A G
AG
Department of Ophthalmology, Taipei Veterans General Hospital, Taiwan, Republic of China.
Liu
R S
RS
Liu
J H
JH
Teng
M M
MM
Yen
M Y
MY
D000328:Adult; D019575:Blindness, Cortical / Q000139:chemically induced / Q000000981:diagnostic imaging*; D005260:Female; D005451:Fluorescein Angiography; D019788:Fluorodeoxyglucose F18; D006801:Humans; D007306:Insecticides / Q000506:poisoning*; D008279:Magnetic Resonance Imaging; D008799:Mevinphos / Q000506:poisoning*; D008875:Middle Aged; D009596:Nitrophenols / Q000506:poisoning*; D062025:Organophosphate Poisoning; D009943:Organophosphorus Compounds; D019275:Radiopharmaceuticals; D014055:Tomography, Emission-Computed / Q000379:methods*; D014792:Visual Acuity; D014793:Visual Cortex / Q000000981:diagnostic imaging* / Q000187:drug effects / Q000473:pathology
D007306:Insecticides; D009596:Nitrophenols; D009943:Organophosphorus Compounds; D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18; C023602:O-4-nitrophenyl phenylphosphonate; D008799:Mevinphos